CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Stay informed and inspired!
Subscribe to our monthly e-newsletter×
A blood test called a liquid biopsy can accurately detect gallbladder, liver, ovarian and pancreatic cancers, correctly finding the disease in at least 4 out of 5 patients. While more clinical testing is needed, these results pave the way for this test to be used as a universal screening tool to help doctors detect cancers earlier in patients. Read more about this breakthrough at The Guardian.